Stemnion, Inc.

Noveome Biotherapeutics, Inc.

Charlotte A Smith

Vivienne S Marshall

Catherine J Trumpower

George L Sing

Richard A Banas

Linda O Palladino

Diana L Clarke

Martin C Robson

The invention is directed to novel cellular factor-containing solution compositions (referred to herein as 'CFS' compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as 'SR-CFS' compositions), methods of making such novel compositions and uses thereof.

Cellular factor-containing solution compositions

Cytokine containing compositions

Methods for treating radiation burns

The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating such substantially purified amnion-derived cell populations, as well as methods of use. The invention is further directed to antibodies, in particular, monoclonal antibodies, that bind to amnion-derived cells or, alternatively, to one or more amnion-derived cell surface protein markers. The invention is further directed to methods for producing the antibodies, methods for using the antibodies, and kits comprising the antibodies.

Amnion-derived cell compositions, methods of making and uses thereof

Kits for treating wounds

Methods for treating wounds

The invention is directed to methods for the treatment of wounds. Such methods utilize novel compositions, including but not limited to amnion-derived multipotent cells (herein referred to as AMP cells), conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine suspension or ACCS), cell lysates derived therefrom, cell products derived therefrom, each alone or in combination.

Methods related to wound healing

The invention is directed to methods related to surgery, for example gastrointestinal surgery. In particular, the invention is methods of treating fistulae, promoting accelerated healing of anastomoses and preventing failure of anastomoses. Such methods utilize novel compositions, including but not limited to extraembryonic cytokine secreting cells (herein referred to as ECS cells), including, but not limited to, amnion-derived multipotent progenitor cells (herein referred to as AMP cells), conditioned media derived therefrom (herein referred to as amnion-derived cellular cytokine solution or ACCS), cell lysates derived therefrom, and cell products derived therefrom, each alone or in combination.

Methods related to surgery

Compositions comprising physiologic concentrations of cytokines

Growing community of inventors

Wexford, PA, United States of America

Charlotte A Smith